RecruitingPhase 2NCT07249463
Rare condition
Coccidioidomycosis
11
studies recruiting now
as of 7 Sept 2026
104
studies registered in total
as of 7 Sept 2026
5
countries with a recruiting site
as of 7 Sept 2026
21 Jul 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT02190266
Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis
RecruitingPhase 2NCT07385638
Olorofim in Early Coccidioidal Meningitis
RecruitingNCT07716410
A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants
RecruitingPhase 2NCT07388615
The Effect of Echinacea (Immulant ®) in the Treatment of CRYPTOSPORIDIOSIS in Immunocompromised Children
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 11 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Coccidioidomycosis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Coccidioidomycosis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
1 approved treatment and 6 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Posaconazole (Noxafil)
Phase 3Fluconazole (Canesten oral)
Phase 3Ibrexafungerp
Phase 2Sertraline
Phase 2Itraconazole (Fungitraxx)
Phase 1/2Nikkomycin
Phase 1Vt-1598
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).